Normal view MARC view ISBD view

Use of the Liverpool Elbow Score as a postal questionnaire for the assessment of outcome after total elbow arthroplasty. [electronic resource]

By:

Ashmore, Alexander M

Contributor(s):

Producer: 20070619Description: S55-8 p. digitalISSN:

1532-6500

Subject(s):

Online resources:

Available from publisher's website

In: Journal of shoulder and elbow surgery vol. 16

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article; Validation Study

There are no comments on this title.

to post a comment.

Back to results

1 Intermittent oral 1alpha-hydroxyvitamin D2 is effective and safe for the suppression of secondary hyperparathyroidism in haemodialysis patients. 1alphaD2 Study Group.
by Frazao, J M
2 Carbamylated hemoglobin in prerenal azotemia.
by Frazao, J M
3 Calcium-sensing receptor and calcimimetic agents.
by Coburn, J W
4 [Significance of digestive hemorrhage in patients with chronic renal insufficiency in hemodialysis].
by Oliveira, C
5 Persistence of antibodies to hepatitis C virus in a chronic hemodialysis population.
by Carrera, F
6 Epstein-Barr-virus-induced interstitial nephritis in an HIV-positive patient with progressive renal failure.
by Frazão, J M
7 Cortical bone analysis in a predialysis population: a comparison with a dialysis population.
by Carvalho, Catarina
8 A calcimimetic agent lowers plasma parathyroid hormone levels in patients with secondary hyperparathyroidism.
by Goodman, W G
9 Femoral bone mineral density reflects histologically determined cortical bone volume in hemodialysis patients.
by Adragao, T
10 Cinacalcet reduces plasma intact parathyroid hormone, serum phosphate and calcium levels in patients with secondary hyperparathyroidism irrespective of its severity.
by Frazão, J M
11 Intermittent doxercalciferol (1alpha-hydroxyvitamin D(2)) therapy for secondary hyperparathyroidism.
by Frazão, J M
12 Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1alpha-hydroxyvitamin D(2)) in dialysis patients with secondary hyperparathyroidism: a sequential comparison.
by Maung, H M